Program Analytics

DW

Drug of Choice, positivity, and population insights

Analytics are about actions: what is rising, who is new to a drug, and where your program differs from the region.

Turnaround time
Positivity trends
Monthly positivity rate by analyte, March to August 2026
Xylazine +7.3 pts since March